Near-infrared spectroscopy as a screening tool for patent ductus arteriosus in extremely low birth weight infants

Neonatology

Volumn 91, Issue 2, 2007, Pages 134-139

  Underwood, Mark A ^a   Milstein, Jay M ^a   Sherman, Michael P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Indomethacin; Near infrared spectroscopy; Patent ductus arteriosus; Preterm infant; Tissue oxygenation saturation

Indexed keywords

INDOMETACIN;

ARTICLE; BRAIN; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; DELTOID MUSCLE; DRUG EFFECT; EARLY INTERVENTION; ECHOCARDIOGRAPHY; EXTREMELY LOW BIRTH WEIGHT; HUMAN; INFANT; KIDNEY; LUNG; MULTIPLE CYCLE TREATMENT; NEAR INFRARED SPECTROSCOPY; OBSERVER VARIATION; OXIMETER; OXYGEN SATURATION; PATENT DUCTUS ARTERIOSUS; PILOT STUDY; PORTABLE EQUIPMENT; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; TISSUE DISTRIBUTION; TREATMENT RESPONSE;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MASS SCREENING; OXYGEN; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY, NEAR-INFRARED;

EID: 33847044295     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000097131     Document Type: Article

References (33)

1. Knight DB: Patent ductus arteriosus: how important to which babies? Early Hum Dev 1992;29:287-292.
2. Evans N, Iyer P: Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995;72:F156-F161.
3. Phillipos EZ, Robertson MA, Byrne PJ: Serial assessment of ductus arteriosus hemodynamics in hyaline membrane disease. Pediatrics 1996;98:1149-1153.
4. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K: Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90:F235-F239.
5. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
6. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM: Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999;104:1345-1350.
7. Lin TW, Su BH, Lin HC, Hu PS, Peng CT, Tsai CH, et al: Risk factors of pulmonary hemorrhage in very-low-birth-weight infants: a two-year retrospective study. Acta Paediatr Taiwan 2000;41:255-258.
8. Shimada S, Kasai T, Hoshi A, Murata A, Chida S: Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 2003;45:255-262.
9. van de Bor M, Verloove-Vanhorick SP, Brand R, Ruys JH: Patent ductus arteriosus in a cohort of 1338 preterm infants: a collaborative study. Paediatr Perinat Epidemiol 1988;2:328-336.
10. Jim WT, Chiu NC, Chen MR, Hung HY, Kao HA, Hsu CH, et al: Cerebral hemodynamic change and intraventricular hemorrhage in very low birth weight infants with patent ductus arteriosus. Ultrasound Med Biol 2005;31:197-202.
11. Wyllie J: Treatment of the patent ductus arteriosus. Semin Neonatol 2003;8:425-432.
12. Laughon MM, Simmons MA, Bose CL: Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004;16:146-151.
13. Van Overmeire B, Chemtob S: The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005;10:177-184.
14. Herrera C, Holberton J, Davis P: Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2004;CD003480.
15. Urquhart DS, Nicholl RM: How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate? Arch Dis Child 2003;88:85-86.
16. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M: Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics 2003;112:e345-e358.
17. Osborn DA, Evans N, Kluckow M: Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2003;88:F477-F482.
18. Alagarsamy S, Chhabra M, Gudavalli M, Sutija VG, Yugrakh D: Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med 2005;33:161-164.
19. Kluckow M, Evans N: Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-779.
20. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L: Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:F419-F422.
21. Narayanan M, Cooper B, Weiss H, Clyman RI: Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 2000;136:330-337.
22. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS, et al: Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005;115:e255-e261.
23. Flynn PA, Da Graca RL, Auld PA, Nesin M, Kleinman CS: The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 2005;147:38-42.
24. Glantz SA: Primer of Biostatistics. CD-ROM version 5.0. New York, McGraw-Hill, 2002, pp 416-437.
25. Wassenaar EB, Van den Brand JGH: Reliability of near-infrared spectroscopy in people with dark skin pigmentation. J Clin Monit Comput 2005;19:195-199.
26. Meek JH, Tyszczuk L, Elwell CE, Wyatt JS: Cerebral blood flow increases over the first three days of life in extremely preterm neonates. Arch Dis Child Fetal Neonatal Ed 1998;78:F33-F37.
27. Fortune PM, Wagstaff M, Petros AJ: Cerebro-splanchnic oxygenation ratio (CSOR) using near infrared spectroscopy may be able to predict splanchnic ischaemia in neonates. Intensive Care Med 2001; 27: 1401-1407.
28. Nicklin SE, Hassan IA, Wickramasinghe YA, Spencer SA: The light still shines, but not that brightly? The current status of perinatal near infrared spectroscopy. Arch Dis Child Fetal Neonatal Ed 2003;88:F263-F268.
29. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delphy DT, Reynolds EOR: Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335:1491-1495.
30. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD: Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42.
31. Cheng F, Mao JM, Kopans DB, Moore RH, Chorlton M: Breast cancer detection by mapping hemoglobin concentration and oxygen saturation: Appl Opt 2003;42:6412-6421.
32. Star WM: Diffusion theory of light transport; in Welch J, van Gemert MJC (eds): Optical-thermal Response of Laser-irradiated Tissue. New York, Plenum Press, 1995, pp 131-206.
33. Kragelj R, Jarm T, Erjavec T, Presern-Strukelj M, Miklavcic D: Parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy in patients with peripheral vascular disease and in healthy volunteers. Ann Biomed Eng 2001;29:311-320.